Arachidonic acid metabolism in human prostate cancer
Open Access
- 10 August 2012
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 41 (4) , 1495-1503
Abstract
The arachidonic acid pathway is important in the development and progression of numerous malignant diseases, including prostate cancer. To more fully evaluate the role of individual cyclooxygenases (COXs), lipoxygenases (LOXs) and their metabolites in prostate cancer, we measured mRNA and protein levels of COXs and LOXs and their arachidonate metabolites in androgen-dependent (LNCaP) and androgen-independent (PC-3 and DU145) prostate cancer cell lines, bone metastasis-derived MDA PCa 2a and MDA PCa 2b cell lines and their corresponding xenograft models, as well as core biopsy specimens of primary prostate cancer and nonneoplastic prostate tissue taken ex vivo after prostatectomy. Relatively high levels of COX-2 mRNA and its product PGE2 were observed only in PC-3 cells and their xenografts. By contrast, levels of the exogenous 12-LOX product 12-HETE were consistently higher in MDA PCa 2b and PC-3 cells and their corresponding xenograft tissues than were those in LNCaP cells. More strikingly, the mean endogenous level of 12-HETE was significantly higher in the primary prostate cancers than in the nonneoplastic prostate tissue (0.094 vs. 0.010 ng/mg protein, respectively; p=0.019). Our results suggest that LOX metabolites such as 12-HETE are critical in prostate cancer progression and that the LOX pathway may be a target for treating and preventing prostate cancer.Keywords
This publication has 48 references indexed in Scilit:
- PGE2 and LTB4 tissue levels in benign and cancerous prostatesProstaglandins & Other Lipid Mediators, 2008
- Cancer survival in five continents: a worldwide population-based study (CONCORD)The Lancet Oncology, 2008
- Cyclooxygenases, prostanoids, and tumor progressionCancer and Metastasis Reviews, 2007
- Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acidsJournal of Clinical Investigation, 2007
- DNA methylation paradigm shift: 15-Lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylationProstaglandins & Other Lipid Mediators, 2007
- The transcription factor GATA‐6 is overexpressed in vivo and contributes to silencing 15‐LOX‐1 in vitro in human colon cancerThe FASEB Journal, 2006
- Activation of the Thromboxane A2 Pathway in Human Prostate Cancer Correlates with Tumor Gleason Score and Pathologic StageEuropean Urology, 2006
- Conditional Expression of Human 15-Lipoxygenase-1 in Mouse Prostate Induces Prostatic Intraepithelial Neoplasia: The FLiMP Mouse ModelNeoplasia, 2006
- Differential Expression of Thromboxane Synthase in Prostate CarcinomaThe American Journal of Pathology, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001